Publications by authors named "E Vodicka"

Claim this Profile
I
Impact of drug utilization management strategies on the incidence and cost of clinical events in patients with non-valvular atrial fibrillation receiving DOACs in the US.
Rupesh Subash, Elisabeth Vodicka, Serina Deeba, Chloe Salter, Carissa Dickerson

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of increased patient out-of-pocket costs on oral anticoagulant discontinuation among Medicare beneficiaries with atrial fibrillation treated with apixaban.
Dominick Latremouille-Viau, Aolin Wang, Dong Cheng, Serina Deeba, Anandkumar Dubey, Elisabeth Vodicka

Curr Med Res Opin· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity.
Michelle Zhang, Risho Singh, Samina Dhuliawala, Dana Stafkey, Elisabeth Vodicka

J Comp Eff Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic Variation in Persistence of Oral Anticoagulant Treatment Among Patients with Non-Valvular Atrial Fibrillation in the United States.
Brett D Atwater, Risho Singh, Ali Bonakdar, Dong Cheng, Serina Deeba, Elisabeth Vodicka

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the long-term economic impact of wheezing episodes after severe RSV disease in children from Argentina: a cost of illness analysis.
Julia Dvorkin, Clint Pecenka, Emiliano M Sosa, Andrea Sancilio, Karina Dueñas, Elisabeth Vodicka

BMJ Public Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis